Director/PDMR Shareholding

Hikma Pharmaceuticals Plc

08 June 2023

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Douglas Hurt
2	Reason for the notification
a)	Position/status	Non-Executive Director
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Market purchase of 1500 Ordinary Shares by Gillian Hurt, spouse of Douglas Hurt
c)	Price(s) and volume(s)	Price(s): £18.20 Volume(s):1500
d)	Aggregated information -       Volume -       Price -       Total	1500  £18.20  £27,300
e)	Date of the transaction	6 June 2023
f)	Place of the transaction	London Stock Exchange (XLON)

Helen Middlemist, Deputy Company Secretary

[phone]

8 June 2023

 

END